Read Zuckerman Faculty Scholar Dr. Gili Bisker’s perspective on Nonequilibrium Self-Assembly, published in Nature Physics
The patent, approved in March, covers a vaccine that targets the most vulnerable point in a coronavirus’s structure, through which it penetrates human cells
Yoav Shechtman, Zuckerman Faculty Scholar and Lucien Weiss, Zuckerman Postdoc Scholar at Technion publish new project in Nature Nanotechnology
Scientists from Tel Aviv University recently identified the receptor chain involved in the development of atopic dermatitis
With the worldwide focus on coronavirus prevention and transmission, a new type of air-filter that self-sterilizes and decontaminates is being developed at Ben-Gurion University
This cellular factory-on-a-chip could be used to design, produce and test drugs against antibiotic resistant bacteria
Weizmann Institute scientists have developed a research platform for designing tiny antibodies that can halt the virus infection process
Dr. Yoav Shechtman is awarded for his continuous attempt to develop new imaging tools for higher and higher resolution and applications in Biophysics.
A study disseminated by Tel Aviv University (TAU) was named in the top 100 most downloaded studies published in 2019, according to Scientific Reports.
The team’s technology is known as Liquid Foam Therapy (LIFT), and is intended to improve the distribution of surfactant.
The new test would supply results 4-10 times faster than the current method.
The Weizmann Institute for Science and Tel Aviv University (TAU) indicated separately that they would begin processing coronavirus tests this week.
We at the Weizmann Institute of Science consider it our duty and privilege to help and contribute to the State and the people of Israel in coping with the global coronavirus crisis.
The Bar-Ilan University Smart Cities Center is set to begin experimenting with an autonomous minibus that can transport patients diagnosed with COVID-19 and medical equipment.
